These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31704232)

  • 1. Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods.
    Kállai V; Lénárd L; Péczely L; Gálosi R; Dusa D; Tóth A; László K; Kertes E; Kovács A; Zagoracz O; Berta B; Karádi Z; Ollmann T
    Behav Brain Res; 2020 Feb; 379():112345. PubMed ID: 31704232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats.
    Kállai V; Tóth A; Gálosi R; Péczely L; Ollmann T; Petykó Z; László K; Kállai J; Szabó I; Karádi Z; Lénárd L
    Behav Brain Res; 2017 Aug; 332():75-83. PubMed ID: 28577920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia.
    Gastambide F; Taylor AM; Palmer C; Svard H; Karjalainen M; Janhunen SK; Tricklebank M; Bannerman DM
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4099-112. PubMed ID: 25633092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
    O'Reilly KC; Perica MI; Fenton AA
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
    Mar AC; Nilsson SRO; Gamallo-Lana B; Lei M; Dourado T; Alsiö J; Saksida LM; Bussey TJ; Robbins TW
    Psychopharmacology (Berl); 2017 Oct; 234(19):2837-2857. PubMed ID: 28744563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working memory deficits in adult rats after prenatal disruption of neurogenesis.
    Gourevitch R; Rocher C; Le Pen G; Krebs MO; Jay TM
    Behav Pharmacol; 2004 Jul; 15(4):287-92. PubMed ID: 15252279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
    Howe WM; Tierney PL; Young DA; Oomen C; Kozak R
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4113-27. PubMed ID: 25963563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral perturbations after prenatal neurogenesis disturbance in female rat.
    Hazane F; Krebs MO; Jay TM; Le Pen G
    Neurotox Res; 2009 May; 15(4):311-20. PubMed ID: 19384565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat.
    Le Pen G; Gourevitch R; Hazane F; Hoareau C; Jay TM; Krebs MO
    Neuroscience; 2006 Dec; 143(2):395-405. PubMed ID: 16973297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
    Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
    Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
    Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
    Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MAM-E17 schizophrenia rat model].
    Kállai V; Tóth A; Gálosi R; Szabó I; Petykó Z; Karádi Z; Kállai J; Lénárd L
    Psychiatr Hung; 2015; 30(1):4-17. PubMed ID: 25867884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
    Hradetzky E; Sanderson TM; Tsang TM; Sherwood JL; Fitzjohn SM; Lakics V; Malik N; Schoeffmann S; O'Neill MJ; Cheng TM; Harris LW; Rahmoune H; Guest PC; Sher E; Collingridge GL; Holmes E; Tricklebank MD; Bahn S
    Neuropsychopharmacology; 2012 Jan; 37(2):364-77. PubMed ID: 21956444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prenatal methylazoxymethanol acetate (MAM) treatment in rats on water maze performance.
    Leng A; Jongen-Rêlo AL; Pothuizen HH; Feldon J
    Behav Brain Res; 2005 Jun; 161(2):291-8. PubMed ID: 15922056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment and training improve cognition in rats with cortical malformations.
    Jenks KR; Lucas MM; Duffy BA; Robbins AA; Gimi B; Barry JM; Scott RC
    PLoS One; 2013; 8(12):e84492. PubMed ID: 24358362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
    Kaneko G; Sanganahalli BG; Groman SM; Wang H; Coman D; Rao J; Herman P; Jiang L; Rich K; de Graaf RA; Taylor JR; Hyder F
    Biol Psychiatry; 2017 Mar; 81(6):503-513. PubMed ID: 27450031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats.
    Péczely L; Dusa D; Lénárd L; Ollmann T; Kertes E; Gálosi R; Berta B; Szabó Á; László K; Zagoracz O; Karádi Z; Kállai V
    Sci Rep; 2024 May; 14(1):12305. PubMed ID: 38811614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal MAM treatment altered fear conditioning following social isolation: Relevance to schizophrenia.
    Bilecki W; Latusz J; Gawlińska K; Chmelova M; Maćkowiak M
    Behav Brain Res; 2021 May; 406():113231. PubMed ID: 33737089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
    Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
    Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.